CoChat

T-Cell Hyperactivation and Paralysis in Severe COVID-19 Infection Revealed by Single-Cell Analysis

Open access
Kalfaoglu, Bahire, Almeida-Santos, José, Tye, Chanidapa Adele, Satou, Yorifumi, Ono, Masahiro · 2020 · Frontiers in Immunology

Published version of a preprint

Cited by 173

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Abstract

Abstract Severe COVID-19 patients can show respiratory failure, T-cell reduction, and cytokine release syndrome (CRS), which can be fatal in both young and aged patients and is a major concern of the pandemic. However, the pathogenetic mechanisms of CRS in COVID-19 are poorly understood. Here we show single cell-level mechanisms for T-cell dysregulation in severe SARS-CoV-2 infection, and thereby demonstrate the mechanisms underlying T-cell hyperactivation and paralysis in severe COVID-19 patients. By in silico sorting CD4+ T-cells from a single cell RNA-seq dataset, we found that CD4+ T-cells were highly activated and showed unique differentiation pathways in the lung of severe COVID-19 patients. Notably, those T-cells in severe COVID-19 patients highly expressed immunoregulatory receptors and CD25, whilst repressing the expression of the transcription factor FOXP3 and interestingly, both the differentiation of regulatory T-cells (Tregs) and Th17 was inhibited. Meanwhile, highly activated CD4 + T-cells express PD-1 alongside macrophages that express PD-1 ligands in severe patients, suggesting that PD-1-mediated immunoregulation was partially operating. Furthermore, we show that CD25 + hyperactivated T-cells differentiate into multiple helper T-cell lineages, showing multifaceted effector T-cells with Th1 and Th2 characteristics. Lastly, we show that CD4 + T-cells, particularly CD25-expressing hyperactivated T-cells, produce the protease Furin, which facilitates the viral entry of SARS-CoV-2. Collectively, CD4 + T-cells from severe COVID-19 patients are hyperactivated and FOXP3-mediated negative feedback mechanisms are impaired in the lung, while activated CD4 + T-cells continue to promote further viral infection through the production of Furin. Therefore, our study proposes a new model of T-cell hyperactivation and paralysis that drives pulmonary damage, systemic CRS and organ failure in severe COVID-19 patients.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fimmu.2020.589380

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 15 references

Research works printed but not linked: 43

  1. Okazaki, 2019, Stimulatory and Inhibitory Co-signals in Autoimmunity, Adv Exp Med Biol, 1189, 10.1007/978-981-32-9717-3_8 · DOI
  2. Bending, 2018, From stability to dynamics: understanding molecular mechanisms of regulatory T cells through Foxp3 transcriptional dynamics, Clin Exp Immunol, 197, 14, 10.1111/cei.13194 · DOI
  3. Hoffmann, 2020, SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor, Cell, 181, 271, 10.1016/j.cell.2020.02.052 · DOI · Paper page
  4. Glowacka, 2011, Evidence that TMPRSS2 Activates the Severe Acute Respiratory Syndrome Coronavirus Spike Protein for Membrane Fusion and Reduces Viral Control by the Humoral Immune Response, J Virol, 85, 10.1128/jvi.02232-10 · DOI · Paper page
  5. Coutard, 2020, The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade, Antiviral Res, 176, 10.1016/j.antiviral.2020.104742 · DOI · Paper page
  6. Pesu, 2008, T-cell-expressed proprotein convertase furin is essential for maintenance of peripheral immune tolerance, Nature, 455, 10.1038/nature07210 · DOI · Paper page
  7. Pesu, 2006, Proprotein convertase furin is preferentially expressed in T helper 1 cells and regulates interferon gamma, Blood, 108, 10.1182/blood-2005-09-3824 · DOI
  8. Oksanen, 2014, Proprotein convertase FURIN constrains Th2 differentiation and is critical for host resistance against Toxoplasma gondii, J Immunol, 193, 10.4049/jimmunol.1401629 · DOI
  9. Huang, 2020, Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China, Lancet, 395, 497, 10.1016/S0140-6736(20)30183-5 · DOI · Paper page
  10. McGonagle, 2020, Immune mechanisms of pulmonary intravascular coagulopathy in COVID-19 pneumonia, Lancet Rheumatol, 2, 10.1016/S2665-9913(20)30121-1 · DOI · Paper page
  11. Shimizu, 1986, Structure and function of the interleukin 2 receptor: affinity conversion model, Immunol Rev, 92, 10.1111/j.1600-065X.1986.tb01496.x · DOI
  12. LaMere, 2016, Promoter H3K4 methylation dynamically reinforces activation-induced pathways in human CD4 T cells, Genes Immun, 17, 10.1038/gene.2016.19 · DOI
  13. Bradley, 2018, Elucidating T Cell Activation-Dependent Mechanisms for Bifurcation of Regulatory and Effector T Cell Differentiation by Multidimensional and Single-Cell Analysis, Front Immunol, 9, 10.3389/fimmu.2018.01444 · DOI
  14. Ishikawa, 2005, Role of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand in Immune Response to Influenza Virus Infection in Mice, J Virol, 79, 10.1128/jvi.79.12.7658-7663.2005 · DOI
  15. Ware, 2011, TNF Superfamily Networks: bidirectional and interference pathways of the herpesvirus entry mediator (TNFSF14), Curr Opin Immunol, 23, 10.1016/j.coi.2011.08.008 · DOI
  16. Gonçalves-Carneiro, 2017, The Measles Virus Receptor SLAMF1 Can Mediate Particle Endocytosis, J Virol, 91, 10.1128/jvi.02255-16 · DOI
  17. Fergusson, 2016, CD161intCD8+ T cells: a novel population of highly functional, memory CD8+ T cells enriched within the gut, Mucosal Immunol, 9, 10.1038/mi.2015.69 · DOI
  18. Bending, 2018, A timer for analyzing temporally dynamic changes in transcription during differentiation in vivo, J Cell Biol, 217, 10.1083/jcb.201711048 · DOI · Paper page
  19. Ono, 2016, Controversies concerning thymus-derived regulatory T cells: fundamental issues and a new perspective, Immunol Cell Biol, 94, 3, 10.1038/icb.2015.65 · DOI
  20. Bailey-Bucktrout, 2013, Self-antigen-driven activation induces instability of regulatory T cells during an inflammatory autoimmune response, Immunity, 39, 10.1016/j.immuni.2013.10.016 · DOI · Paper page
  21. Miyao, 2012, Plasticity of Foxp3(+) T cells reflects promiscuous Foxp3 expression in conventional T cells but not reprogramming of regulatory T cells, Immunity, 36, 10.1016/j.immuni.2011.12.012 · DOI · Paper page
  22. O’Malley, 2009, Signal transducer and activator of transcription 4 limits the development of adaptive regulatory T cells, Immunology, 127, 10.1111/j.1365-2567.2008.03037.x · DOI · Paper page
  23. Zhou, 2008, TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function, Nature, 453, 10.1038/nature06878 · DOI · Paper page
  24. Miyara, 2009, Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor, Immunity, 30, 899, 10.1016/j.immuni.2009.03.019 · DOI · Paper page
  25. Schönrich, 2019, The PD-1/PD-L1 Axis and Virus Infections: A Delicate Balance, Front Cell Infect Microbiol, 9, 10.3389/fcimb.2019.00207 · DOI · Paper page
  26. Trinchieri, 2007, Interleukin-10 production by effector T cells: Th1 cells show self control, J Exp Med, 204, 10.1084/jem.20070104 · DOI · Paper page
  27. Roncarolo, 2018, The Biology of T Regulatory Type 1 Cells and Their Therapeutic Application in Immune-Mediated Diseases, Immunity, 49, 10.1016/j.immuni.2018.12.001 · DOI · Paper page
  28. Brockmann, 2017, IL-10 Receptor Signaling Is Essential for TR1 Cell Function In Vivo, J Immunol, 198, 10.4049/jimmunol.1601045 · DOI
  29. Couper, 2008, IL-10: The Master Regulator of Immunity to Infection, J Immunol, 180, 10.4049/jimmunol.180.9.5771 · DOI · Paper page
  30. Ono, 2007, Foxp3 controls regulatory T-cell function by interacting with AML1/Runx1, Nature, 446, 10.1038/nature05673 · DOI · Paper page
  31. Bending, 2018, A temporally dynamic Foxp3 autoregulatory transcriptional circuit controls the effector Treg programme, EMBO J, 37, 10.15252/embj.201899013 · DOI · Paper page
  32. Meng, 2012, Statins induce the accumulation of regulatory T cells in atherosclerotic plaque, Mol Med (Cambridge Mass.), 18, 598, 10.2119/molmed.2011.00471 · DOI
  33. George, 2012, Regulatory T cells and IL-10 levels are reduced in patients with vulnerable coronary plaques, Atherosclerosis, 222, 10.1016/j.atherosclerosis.2012.03.016 · DOI
  34. De Rosa, 2007, A Key Role of Leptin in the Control of Regulatory T Cell Proliferation, Immunity, 26, 10.1016/j.immuni.2007.01.011 · DOI · Paper page
  35. Visperas, 2016, Are Regulatory T Cells Defective in Type 1 Diabetes and Can We Fix Them, J Immunol (Baltimore Md 1950), 197, 10.4049/jimmunol.1601118 · DOI
  36. Gabriel, 2016, Sugars and fat – A healthy way to generate functional regulatory T cells, Eur J Immunol, 46, 10.1002/eji.201646663 · DOI
  37. McNally, 2013, Local Blockade of Epithelial PDL-1 in the Airways Enhances T Cell Function and Viral Clearance during Influenza Virus Infection, J Virol, 87, 10.1128/jvi.02423-13 · DOI · Paper page
  38. Stanciu, 2006, Expression of Programmed Death–1 Ligand (PD-L) 1, PD-L2, B7-H3, and Inducible Costimulator Ligand on Human Respiratory Tract Epithelial Cells and Regulation by Respiratory Syncytial Virus and Type 1 and 2 Cytokines, J Infect Dis, 193, 10.1086/499275 · DOI
  39. Pipkin, 2009, SnapShot: effector and memory T cell differentiation, Cell, 138, 606.e601, 10.1016/j.cell.2009.07.020 · doi:10.1016/j.cell.2009.07.020
  40. Furmanski, 2013, Tissue-Derived Hedgehog Proteins Modulate Th Differentiation and Disease, J Immunol, 190, 10.4049/jimmunol.1202541 · DOI
  41. Kuczma, 2009, Foxp3-Deficient Regulatory T Cells Do Not Revert into Conventional Effector CD4+ T Cells but Constitute a Unique Cell Subset, J Immunol, 183, 10.4049/jimmunol.0800601 · DOI
  42. Pedersen, 2009, CD25 Shedding by Human Natural Occurring CD4+CD25+ Regulatory T Cells does not Inhibit the Action of IL-2, Scand J Immunol, 70, 10.1111/j.1365-3083.2009.02268.x · doi:10.1111/j.1365-3083.2009.02268.x
  43. Jiang, 2019, Improving the safety of CAR-T cell therapy by controlling CRS-related coagulopathy, Ann Hematol, 98, 10.1007/s00277-019-03685-z · DOI

Cited by

See all 173

Metadata

Authors
Kalfaoglu, B., Almeida-Santos, J., Tye, C. A., Satou, Y., & Ono, M.
Venue
Frontiers in Immunology
Published
2020-10-08
Volume
11
Pages
589380-589380
ISSN
1664-3224 (ISSN-L)
OpenAlex
W3092490718
Cited by
173
References
15
FWCI
4.22
Type
journal article
Language
en
Open access
gold
Funders
  • Medical Research Council
  • Japan Society for the Promotion of Science
  • Japan Agency for Medical Research and Development

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: T-Cell Hyperactivation and Paralysis in Severe COVID-19 Infection Revealed by Single-Cell Analysis. https://app.cochat.ai/papers/10.3389/fimmu.2020.589380
The paper
Kalfaoglu, B., Almeida-Santos, J., Tye, C. A., Satou, Y., & Ono, M. (2020). T-Cell Hyperactivation and Paralysis in Severe COVID-19 Infection Revealed by Single-Cell Analysis. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2020.589380

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.